BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35174530)

  • 1. Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α
    Tai HC; Wang SW; Swain S; Lin LW; Tsai HC; Liu SC; Wu HC; Guo JH; Liu CL; Lai YW; Lin TH; Yang SF; Tang CH
    J Pineal Res; 2022 Apr; 72(3):e12793. PubMed ID: 35174530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy.
    Shiu SY; Leung WY; Tam CW; Liu VW; Yao KM
    J Pineal Res; 2013 Jan; 54(1):69-79. PubMed ID: 22856547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression.
    Wang SW; Tai HC; Tang CH; Lin LW; Lin TH; Chang AC; Chen PC; Chen YH; Wang PC; Lai YW; Chen SS
    J Cell Physiol; 2021 May; 236(5):3979-3990. PubMed ID: 33251599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.
    Jin R; Sterling JA; Edwards JR; DeGraff DJ; Lee C; Park SI; Matusik RJ
    PLoS One; 2013; 8(4):e60983. PubMed ID: 23577181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype.
    Shiu SY; Law IC; Lau KW; Tam PC; Yip AW; Ng WT
    J Pineal Res; 2003 Oct; 35(3):177-82. PubMed ID: 12932201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.
    Sottnik JL; Daignault-Newton S; Zhang X; Morrissey C; Hussain MH; Keller ET; Hall CL
    Clin Exp Metastasis; 2013 Jun; 30(5):569-78. PubMed ID: 23242739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
    Samanta S
    Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model.
    Jung-Hynes B; Schmit TL; Reagan-Shaw SR; Siddiqui IA; Mukhtar H; Ahmad N
    J Pineal Res; 2011 Mar; 50(2):140-9. PubMed ID: 21062352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases.
    Delliaux C; Tian TV; Bouchet M; Fradet A; Vanpouille N; Flourens A; Deplus R; Villers A; Leroy X; Clézardin P; de Launoit Y; Bonnelye E; Duterque-Coquillaud M
    Cancer Lett; 2018 Dec; 438():32-43. PubMed ID: 30201302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.
    Lee SH; Hatakeyama S; Yu SY; Bao X; Ohyama C; Khoo KH; Fukuda MN; Fukuda M
    J Biol Chem; 2009 Jun; 284(25):17157-17169. PubMed ID: 19395705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PSCA/PGRN-NF-κB-Integrin-α4 Axis Promotes Prostate Cancer Cell Adhesion to Bone Marrow Endothelium and Enhances Metastatic Potential.
    Zhao Z; Li E; Luo L; Zhao S; Liu L; Wang J; Kang R; Luo J
    Mol Cancer Res; 2020 Mar; 18(3):501-513. PubMed ID: 31722969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gleditsia sinensis Thorn Attenuates the Collagen-Based Migration of PC3 Prostate Cancer Cells through the Suppression of α2β1 Integrin Expression.
    Ryu S; Park KM; Lee SH
    Int J Mol Sci; 2016 Mar; 17(3):328. PubMed ID: 26950116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
    Xi SC; Siu SW; Fong SW; Shiu SY
    Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression.
    Van Slambrouck S; Hilkens J; Bisoffi M; Steelant WF
    Int J Oncol; 2009 Oct; 35(4):693-9. PubMed ID: 19724904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits lung metastasis of gastric cancer in vivo.
    Wang X; Wang B; Zhan W; Kang L; Zhang S; Chen C; Hou D; You R; Huang H
    Biomed Pharmacother; 2019 Sep; 117():109018. PubMed ID: 31176166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
    Ramirez NE; Zhang Z; Madamanchi A; Boyd KL; O'Rear LD; Nashabi A; Li Z; Dupont WD; Zijlstra A; Zutter MM
    J Clin Invest; 2011 Jan; 121(1):226-37. PubMed ID: 21135504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-pinitol inhibits prostate cancer metastasis through inhibition of αVβ3 integrin by modulating FAK, c-Src and NF-κB pathways.
    Lin TH; Tan TW; Tsai TH; Chen CC; Hsieh TF; Lee SS; Liu HH; Chen WC; Tang CH
    Int J Mol Sci; 2013 May; 14(5):9790-802. PubMed ID: 23698767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
    Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.